BRIEF published on 08/15/2024 at 07:05, 3 months 6 days ago Ikonisys completes a capital increase of €150,000 Private Placement Funding Capital Increase New Actions Ikonisys
PRESS RELEASE published on 08/15/2024 at 07:00, 3 months 6 days ago Inside Information / Other news releases Ikonisys completes €150k capital increase via private placement to strengthen financial resources and support working capital needs, enhancing shareholder base and financial visibility Private Placement Capital Increase Financial Resources Shareholder Base Ikonisys
BRIEF published on 07/23/2024 at 10:11, 3 months 29 days ago Ikonisys SA Receives Buy Rating Despite Lower 2023 Figures Private Placement Financial Results 2023 Performance Sphene Capital Ikonisys
PRESS RELEASE published on 07/23/2024 at 10:06, 3 months 29 days ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Sphene Capital GmbH updates research report on Ikonisys SA, adjusting price target to EUR 5.50 from EUR 6.30. Company's 2023 financial figures below expectations, 2024 forecasts driven by collaborations Financial Figures Ikonisys SA Price Target Collaborations Sphene Capital GmbH
BRIEF published on 07/18/2024 at 19:10, 4 months 2 days ago Ikonisys Completes €250k Capital Increase Via Private Placement Private Placement Capital Increase Financial Resources Cancer Detection Ikonisys
PRESS RELEASE published on 07/18/2024 at 19:05, 4 months 2 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Ikonisys completed a €250k capital increase through a private placement with CC Holding Srl to strengthen financial resources for commercial development Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
BRIEF published on 06/11/2024 at 18:35, 5 months 9 days ago Ikonisys and Ulisse Biomed enter into a strategic partnership for cancer diagnosis Innovation Biotechnology Partnership Diagnostic Cancer
PRESS RELEASE published on 06/11/2024 at 18:30, 5 months 9 days ago Inside Information / Other news releases Ikonisys and Ulisse Biomed announce strategic partnership to enhance cancer diagnostics through technical and commercial collaboration, aiming to provide innovative solutions and maximize market penetration Innovation Strategic Partnership Cancer Diagnostics Ikonisys Ulisse Biomed
BRIEF published on 06/03/2024 at 21:04, 5 months 17 days ago Ikonisys Completes Capital Increase to Boost Commercial Expansion Private Placement Capital Increase Commercial Expansion Ikonisys Hospitex Integration
PRESS RELEASE published on 06/03/2024 at 20:59, 5 months 17 days ago Inside Information / Other news releases Ikonisys announces €150k capital increase through private placement to accelerate commercial development. New funds strengthen financial resources for expansion Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
Published on 11/21/2024 at 14:15, 15 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 30 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 30 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 30 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 14 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 15 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 55 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 45 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
